Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1251821

registered interest
date	12/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has provided to (a) Clinical Commissioning Groups and (b) local NHS providers on the introduction of new antimicrobials; and how this guidance supports the antimicrobial resistance five-year action plan.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	114964
answer	answer is ministerial correction date of answer 14/01/2021 answer text <p>Optimising the use of antimicrobials is central to the United Kingdom’s efforts to tackle antimicrobial resistance (AMR). The UK’s five-year national action plan for AMR sets the ambition to reduce UK antimicrobial use in humans by 15% by 2024.</p><p>The National Institute for Health and Care Excellence (NICE) supports stewardship of current and new antimicrobials through its Managing Common Infections antimicrobial prescribing guidelines for all care settings.</p><p>NICE also produces Evidence Summaries of the best available information on an antimicrobial to guide decision-making, both nationally within NHS England and NHS Improvement and locally, for example within a clinical commissioning group, a National Health Service trust, or across a local health economy.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 14/01/2021 16:02:29 answering member 4380 label Biography information for Jo Churchill previous answer version 62027 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1251822

registered interest
date	12/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans are in place to ensure that the devolved nations can benefit from the initiatives in England to incentivise the development of new antimicrobials through innovative models for the evaluation and purchase of antimicrobials; and what the timeframe is for the roll-out of those initiatives.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	114965
answer	answer is ministerial correction date of answer 14/01/2021 answer text <p>The National Institute for Health and Care Excellence and NHS England and NHS Improvement are undertaking work to develop and test an innovative model for the evaluation and purchase of antimicrobials that will help incentivise investment in these drugs. The model will initially be tested through application to two antimicrobial products to be selected through a competitive procurement exercise currently underway. Successful products will undergo adapted Health Technology Assessments throughout 2021, and contracts between suppliers and the NHS in England are anticipated to start from April 2022.</p><p> </p><p>It will be important to evaluate the model thoroughly before considering changes to routine commissioning policy. The devolved administrations are important stakeholders to the project and we continue to work with them to ensure the model is suitable for contexts in Scotland, Wales and Northern Ireland.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 14/01/2021 16:04:42 answering member 4380 label Biography information for Jo Churchill previous answer version 62028 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1250488

registered interest
date	10/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to record the vaccination status of people who have received the covid-19 vaccine.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	113601
answer	answer is ministerial correction date of answer 02/12/2020 answer text <p>The careful and accurate recording of vaccination status is incredibly important both in terms of ensuring priority cohorts are offered the two doses of a potential COVID-19 vaccination and to ensure robust surveillance systems are in place to support patient safety.</p><p> </p><p>The National Health Service National Immunisation Management System (NIMS) will be used as the national register of COVID-19 vaccinations. At the point that someone receives their COVID-19 vaccine, the vaccinating team will record it and this information will go onto the NIMS system and onto a patient’s general practitioner record.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/12/2020 16:48:10 answering member 4380 label Biography information for Jo Churchill previous answer version 61590 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1250490

registered interest
date	10/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to introduce health passports as part of its future covid-19 vaccine roll-out strategy.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	113603
answer	answer is ministerial correction date of answer 24/11/2020 answer text <p>Whilst deployment of a safe and effective COVID-19 vaccine would be a significant step forward, we do not yet know what impact this will have on the current wave of the pandemic. We first need to improve understanding of the any potential vaccine in order to fully understand the potential of health passports as part of our future COVID-19 vaccine roll-out-strategy.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/11/2020 15:45:41 answering member 4380 label Biography information for Jo Churchill previous answer version 61592 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1201407

registered interest
date	08/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that NICE recommendations for newly licensed medicines for (a) blood cancer and (b) multiple myeloma are not delayed as a result of the covid-19 pandemic.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	56072
answer	answer is ministerial correction date of answer 24/06/2020 answer text <p>In response to the COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) adapted its priorities to support the National Health Service, local authorities and the wider health and social care sector. In March, NICE paused the publication of topics that were not COVID-19-related or therapeutically critical to avoid distracting the NHS at a time of unprecedented pressure. However, on 1 June NICE began a phased restart of publishing guidance that had previously been paused.</p><p>All cancer appraisals were identified as being therapeutically critical and kept to their planned timelines. NICE is currently developing guidance on eight technologies for treating multiple myeloma and leukaemia, and the timescales for these are available at the following link:</p><p><a href="https://www.nice.org.uk/search?om=%5b%7b%22gst%22:%5b%22In%20development%22%5d%7d%5d&amp;ps=15&amp;q=blood+cancer&amp;sp=on" target="_blank">https://www.nice.org.uk/search?om=[{%22gst%22:[%22In%20development%22]}]&amp;ps=15&amp;q=blood+cancer&amp;sp=on</a></p><p>NICE is an independent body and is responsible for the methods it uses in developing its guidance. NICE is currently undertaking a review of its methods for health technology evaluation.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 56073 question first answered 24/06/2020 14:41:16 answering member 4380 label Biography information for Jo Churchill previous answer version 28227 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1201408

registered interest
date	08/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment has been made of the effectiveness of NICE’s methodology for assessing combination therapies.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	56073
answer	answer is ministerial correction date of answer 24/06/2020 answer text <p>In response to the COVID-19 pandemic, the National Institute for Health and Care Excellence (NICE) adapted its priorities to support the National Health Service, local authorities and the wider health and social care sector. In March, NICE paused the publication of topics that were not COVID-19-related or therapeutically critical to avoid distracting the NHS at a time of unprecedented pressure. However, on 1 June NICE began a phased restart of publishing guidance that had previously been paused.</p><p>All cancer appraisals were identified as being therapeutically critical and kept to their planned timelines. NICE is currently developing guidance on eight technologies for treating multiple myeloma and leukaemia, and the timescales for these are available at the following link:</p><p><a href="https://www.nice.org.uk/search?om=%5b%7b%22gst%22:%5b%22In%20development%22%5d%7d%5d&amp;ps=15&amp;q=blood+cancer&amp;sp=on" target="_blank">https://www.nice.org.uk/search?om=[{%22gst%22:[%22In%20development%22]}]&amp;ps=15&amp;q=blood+cancer&amp;sp=on</a></p><p>NICE is an independent body and is responsible for the methods it uses in developing its guidance. NICE is currently undertaking a review of its methods for health technology evaluation.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 56072 question first answered 24/06/2020 14:41:16 answering member 4380 label Biography information for Jo Churchill previous answer version 28228 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1201409

registered interest
date	08/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what treatment options are available to patients with multiple myeloma who have become refractory to previous lines of therapy.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	56074
answer	answer is ministerial correction date of answer 01/07/2020 answer text <p>For patients who have received previous lines of treatment, the National Institute for Health and Care Excellence (NICE) currently recommends the following subsequent treatments in England:</p><p>- Daratumumab with bortezomib and dexamethasone (NICE TA573);</p><p>- Carfilzomib (NICE TA 457);</p><p>- Bortezomib (NICE TA 129); and</p><p>- Ixazomib with lenalidomide and dexamethasone (NICE TA505).</p><p> </p><p>For some patients, stem cell transplantation may also be considered, however, the treatment is very intensive and requires a good level of fitness.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 01/07/2020 17:21:25 answering member 4380 label Biography information for Jo Churchill previous answer version 28229 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1200469

registered interest
date	04/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Ethnic Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, for what reason the Public Health England review of the effect of covid-19 on BAME communities did not refer to (a) the high proportion of BAME healthcare workers who died from covid-19 and (b) the sociocultural circumstances of BAME victims which affected their exposure to covid-19; and what steps he plans to take to protect BAME communities from covid-19.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	54970
answer	answer is ministerial correction date of answer 01/07/2020 answer text <p>Public Health England (PHE) led a rapid review to better understand how different factors can impact on how people are affected by COVID-19. This includes analysis of ethnicity, deprivation, age, sex (male and female) and obesity, where surveillance data was available to PHE.</p><p> </p><p>The review also referred to findings from other studies, where possible, including those analysing the deaths of black, Asian and minority ethnic (BAME) National Health Service staff and sociocultural circumstances of BAME communities.</p><p> </p><p>The Parliamentary Under-Secretary of State for Equalities (Kemi Badenoch MP) will be taking forward work to better understand the drivers behind the report’s conclusions and interactions between different risk factors and consider where further data or analysis is needed. The Terms of Reference for that work can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/next-steps-for-work-on-covid-19-disparities-announced" target="_blank">https://www.gov.uk/government/news/next-steps-for-work-on-covid-19-disparities-announced</a></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 01/07/2020 17:17:32 answering member 4380 label Biography information for Jo Churchill previous answer version 27466 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1200471

registered interest
date	04/06/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Ethnic Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with his Scottish Government counterpart on the heightened effect of covid-19 on BAME communities.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	54972
answer	answer is ministerial correction date of answer 18/06/2020 answer text <p>The Department is regularly in discussions with the devolved administrations at both ministerial and official level on a wide range of issues relating to COVID-19. COVID-19 presents a global challenge which requires a collaborative response. The Department will continue to work with the devolved administrations throughout the crisis and beyond.</p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/06/2020 16:31:08 answering member 4380 label Biography information for Jo Churchill previous answer version 27467 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day

1185802

registered interest
date	17/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Public Health
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has for public information adverts on terrestrial television to advise the public during the covid-19 outbreak; and if will make a statement.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	30845
answer	answer is ministerial correction date of answer 02/04/2020 answer text <p>On 15 March, a new television advertising campaign was included in to official efforts to ensure the public is aware of the best way to limit and delay the spread of COVID-19.</p><p>As well as television, the campaign advice is featuring in newspapers and magazines, on drive-time radio, online and through social media and on billboards and large digital displays, including at bus stops.</p><p>Additionally, the Prime Minister is holding daily televised press conference to update the nation on the latest measures taken in the fight against COVID-19.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 02/04/2020 15:41:33 answering member 4527 label Biography information for Helen Whately previous answer version 13989 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	4488 label Biography information for Martyn Day